The application provides a use of remdesivir in preparation of a preparation for preventing and / or treating
peste des petits ruminants virus, and belongs to the technical field of biological
medicine. The application finds that the use of remdesivir in a safe concentration range can significantly inhibit the replication of the
peste des petits ruminants virus in host cells, obviously reduce the expression level of
virus-related genes and proteins, and exhibit good antiviral activity. Meanwhile, the
inhibitory effect of remdesivir on the PPRV presents obvious
dose dependence, and with the increase of the acting concentration, the antiviral effect is significantly enhanced, which indicates that the effect is stable and has strong
controllability. Moreover, remdesivir mainly acts on the virus replication stage, can effectively block the virus
replication process, thereby reducing the virus infection level and reducing the generation of
daughter virus particles. The application provides a new technical approach for the prevention and treatment of
peste des petits ruminants, makes up for the deficiency of lack of effective antiviral drugs in the prior art, and has a good application prospect.